The test would be a randomized, controlled, double-blind Phase 3 trial, or large-scale testing on humans -- the last step before regulatory approval.The US pharmaceutical company's subsidiary Janssen will test the vaccine on 7,000 volunteers across seven states in Brazil

from Livemint - Science https://ift.tt/3g9EMei
https://ift.tt/eA8V8J

Post a Comment

Previous Post Next Post